ANGLE (AGL): Corp Ovarian cancer study update – positive first step | Intercede (IGP): Corp Delivering on promises | K3 Capital (K3C): Corp Timing of growth should not detract from inherent quality
05 Jun 2019
Morning Note – 5 June 2019
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 5 June 2019
- Published:
05 Jun 2019 -
Author:
Andrew Darley | Mark Brewer | Cavendish Research -
Pages:
5
ANGLE (AGL): Corp Ovarian cancer study update – positive first step | Intercede (IGP): Corp Delivering on promises | K3 Capital (K3C): Corp Timing of growth should not detract from inherent quality